Four studies reported that inhibition of IL-1β or the IL-1R in AAA experimental models developed using elastase perfusion or angiotensin II infusion resulted in smaller AAA size as compared to control mice [33,34,35,44]. This evidence concerns the gene IL1R1 and triple-A syndrome.